GAIN: a multicenter pilot protocol for early initiation of enteral feeds in neonates with simple gastroschisis.
Nicole T Cacho, Anjali J Cera, Daniel J Tancredi...
https://pubmed.ncbi.nlm.nih.gov/42298737/Actively Recruiting
Led by University of California, Davis · Updated on 2026-03-17
20
Participants Needed
2
Research Sites
52 weeks
Total Duration
Researchers are evaluating the feasibility of starting early feeding in newborns with gastroschisis, a condition where the intestines develop outside the body. The study focuses on infants born at 34 weeks or later who have simple gastroschisis and are stable after surgery. This trial aims to understand if initiating feeds early is practical and how well infants tolerate and adhere to the feeding protocol. The study involves an early feeding protocol where human milk feeding begins within 48 hours of surgical repair and removal of the Replogle tube within 24 hours after abdominal closure. Feeds are gradually increased based on the infants tolerance and clinical assessments, with attention to supporting oral motor skill development. This intervention takes place from the prenatal period through hospital discharge, averaging about 90 days. Participants will be monitored closely from enrollment soon after birth until hospital discharge. Researchers will assess feasibility of enrollment, adherence to the feeding protocol, fidelity to the treatment plan, and reasons for any withdrawal from the protocol. The study also observes clinical stability throughout the feeding advancement period. Overall, the trial seeks to gather detailed information on the early feeding process and outcomes in this newborn population.
CONDITIONS
Early Feeds in Gastroschisis
N
Nicole Cacho, DO
G
Geoanna Bautista, MD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University of California, Davis
Lead Sponsor
The Gerber Foundation
Collaborating Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | Early Feeding Protocol | Conventional Feeding Protocol (Current Care) |
|---|---|---|
| What it is | A standardized feeding approach where the nasogastric (Replogle) tube is removed within 24 hours after abdominal closure and introductory enteral feeds start within 48 hours for neonates with simple gastroschisis. | Traditional care where enteral (oral) feeds are delayed after abdominal closure, based on the neonate’s tolerance, signs of bowel function return, or clinical recovery. Feeds typically start later and advance more slowly than in early feeding protocols. |
| Role in trial | The investigational protocol evaluated in all eligible neonates; no concurrent control group is included in the study. | Represents the conventional-care pathway used prior to or outside of the early feeding protocol trial for otherwise similar neonates. |
| Primary use | To determine the feasibility, adherence, and initial safety of rapid feed introduction in hemodynamically stable neonates after repairs for simple gastroschisis. | To support recovery after surgical repair of gastroschisis by cautiously initiating feeds once the neonate shows established bowel function and clinical stability, minimizing complications such as feeding intolerance. |
| How it is given or performed | After abdominal closure, the nasogastric tube is removed within 24 hours and the first enteral feed is started within 48 hours, with feeds advanced per protocol guidelines if tolerated. | Removal of gastric tube and introduction of oral feeds are decided by clinical judgment, usually delayed until there are clear signs of bowel function. Feed advancement proceeds cautiously and is individually titrated. |
| Evidence status | Pilot and retrospective studies show that early feeding protocols are feasible and may reduce time to full feeds and length of hospital stay, but large-scale prospective evidence is limited. | Outcomes are supported by multiple cohort studies showing variable time to full feeds, length of stay, and risk of complications such as feeding intolerance using traditional delayed protocols. |
| Important limitations | Current evidence is limited to pilot and observational data with small sample sizes; risks of feeding intolerance, complications, or protocol deviations remain to be clarified in larger studies. | Delayed feeding protocols vary in practice, may prolong hospital stay, and standardization is lacking; retrospective studies may miss clinically important outcomes. |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Approximately 90 days until hospital discharge
Participants undergo surgical repair of gastroschisis followed by an early feeding protocol starting within 48 hours of abdominal closure. Feeds are advanced based on tolerance and clinical assessment to support oral motor skill development.
Visits as part of hospital care until discharge
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Nicole T Cacho, Anjali J Cera, Daniel J Tancredi...
https://pubmed.ncbi.nlm.nih.gov/42298737/Daniel A DeUgarte, Kara L Calkins, Yigit Guner...
https://pubmed.ncbi.nlm.nih.gov/31704046/Donna Hobson, Kaye Spence, Amit Trivedi...
https://pubmed.ncbi.nlm.nih.gov/31801489/Jeewan Jyoti, Kristen James-Nunez, Kaye Spence...
https://pubmed.ncbi.nlm.nih.gov/39206671/University of California, Davis
Lead Sponsor
The Gerber Foundation
Collaborating Sponsor